Crowdonomics
WatchlistPortfolio
All companies
AccuShoot logo

AccuShoot

Operating

AccuShoot, Inc.

Founded 2020

Visit website
Post-money valuation ⓘ
$17.2M
As of Mar 2025 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$1,699,520
Crowd $1.2M · Private $500K · 2 rounds since 2020
Latest share price
$4.00
Reg CF · Common Stock · Mar 2023 offering price

Financials

FY2020–FY2025 (no data for FY2022) · from SEC filings · hover any figure for its source
$0
−$419K
2020
$50K
−$1.2M
2021
2022no data
$846
−$229K
2023
$22K
−$183K
2024
$285K
−$1.4M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
FY2023 reviewed
FY2024 reviewed
FY2025
Income statement
Revenue
$0
$49,713
$846
$22,001
$285,178
Cost of goods sold
$0
$0
$38
$4,854
$235,045
Gross margin
—
100%
96%
78%
18%
Net income
-$419,403
-$1,155,235
-$229,118
-$182,708
-$1,443,952
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$40,597
$170
$1,890
$45,370
$36,561
Accounts receivable
$0
$0
$180
$10,628
$27,685
Total assets
$580,597
$490,170
$2,268,759
$4,089,547
$6,057,889
Short-term debt
$0
$1,063,933
$119,709
$132,837
$531,740
Long-term debt
$0
$500
$3,879,385
$5,607,400
$5,797,305
Total liabilities
$0
$1,064,433
$3,999,094
$5,740,237
$6,329,045
Other
Headcount
—
0
—
0
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$16.0M
pre-money
Reg CF · Common · Mar 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Mar 2023Closedvia Netcapital
Raised $1.2M / $1.2MPost-money $17.2M
Rule 506(b) · Equity · Aug 2020Closed
Raised $500KInvestors 9

Team

3 people
Francisco Martin
Principal Executive Officer
Javier Placer
Board Member
Poul Petersen
Board Member

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 2 of 4 annual reports (FY2022–FY2025)

9 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 21 filings on EDGAR
  • Form C-TRMay 20, 20260001825796-26-000005
    EDGAR
  • Form C-ARMay 20, 20260001825796-26-000004
    EDGAR
  • Form C-ARMay 20, 20260001825796-26-000003
    EDGAR
  • Form C-UApr 9, 20250001669191-25-000261
    EDGAR
  • Form C/AMar 24, 20250001669191-25-000169
    EDGAR
  • Form C/AFeb 28, 20250001669191-25-000133
    EDGAR
  • Form C/ADec 6, 20240001669191-24-001105
    EDGAR
  • Form C/AOct 11, 20240001669191-24-000981
    EDGAR
Source: ManualCIK 0001825796Share price $4.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.